Cigna

The Cigna Group Foundation Offers $250K Grants to Memphis Nonprofits for Health Care Access

Cigna Foundation Offers $250K in Grants to Memphis Nonprofits to Expand Health Care Access The The Cigna Group Foundation has announced a significant expansion of its Impact Fund to Memphis, reinforcing its long-standing commitment to improving community health outcomes across…

Read MoreThe Cigna Group Foundation Offers $250K Grants to Memphis Nonprofits for Health Care Access
United

United Healthcare Cuts Prior Authorizations, Speeds Rural Provider Payments

UnitedHealthcare Eases Prior Authorizations, Speeds Payments for Rural Providers Nationwide UnitedHealthcare has unveiled a sweeping expansion of its rural health care strategy, introducing a set of nationwide initiatives aimed at strengthening independent rural hospitals, easing administrative burdens, and improving access…

Read MoreUnited Healthcare Cuts Prior Authorizations, Speeds Rural Provider Payments
Lundbeck

Lundbeck Shares AAN 2026 Data on Cognitive Symptom Improvement with VYEPTI in Migraine Patients

Lundbeck Shares AAN 2026 Data Showing Real-World Cognitive Improvements in Migraine Patients Treated with VYEPTI Lundbeck today presented new real-world 6-month results from the INFUSE study at the American Academy of Neurology (AAN) 2026 Annual Meeting, underscoring the importance of evaluating the…

Read MoreLundbeck Shares AAN 2026 Data on Cognitive Symptom Improvement with VYEPTI in Migraine Patients
Definium

Definium Therapeutics Backs White House Push for Psychedelic Mental Health Treatments

Definium Therapeutics Supports White House Order to Advance Psychedelic Mental Health Treatments Definium Therapeutics a late-stage clinical biopharmaceutical company focused on addressing the root causes of psychiatric and neurological disorders, has publicly expressed its support for a newly signed White…

Read MoreDefinium Therapeutics Backs White House Push for Psychedelic Mental Health Treatments
Compass

Compass Pathways Applauds White House Order to Fast-Track Psychedelic Research and Access

Compass Pathways Backs White House Initiative to Accelerate Psychedelic Treatments for Mental Health Compass Pathways plc a biotechnology company focused on expanding access to evidence-based mental health innovations, has expressed strong support for a recent White House Executive Order aimed…

Read MoreCompass Pathways Applauds White House Order to Fast-Track Psychedelic Research and Access
HSS

HSS Highlights AI-Driven Pain Risk Insights and Anesthesia Education Research at ASRA Meeting

HSS Research Highlights AI’s Growing Role in Predicting Pain Risk and Improving Anesthesia Education At the American Society of Regional Anesthesia and Acute Pain Medicine (ASRA) annual meeting, researchers from Hospital for Special Surgery (HSS) unveiled new findings demonstrating how…

Read MoreHSS Highlights AI-Driven Pain Risk Insights and Anesthesia Education Research at ASRA Meeting
Zai-Lab-

Zai Lab Highlights ZL-1503’s Rapid Itch Relief and Anti-Inflammatory Potential in Atopic Diseases

Zai Lab Showcases ZL-1503’s Rapid Itch Relief and Anti-Inflammatory Effects in Atopic Diseases Zai Lab Limited has unveiled new preclinical findings highlighting the therapeutic promise of ZL-1503, an investigational bispecific antibody designed to simultaneously target IL-13 and IL-31Rα pathways. The…

Read MoreZai Lab Highlights ZL-1503’s Rapid Itch Relief and Anti-Inflammatory Potential in Atopic Diseases